0001416038-11-000001.txt : 20111017 0001416038-11-000001.hdr.sgml : 20111017 20111017112014 ACCESSION NUMBER: 0001416038-11-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111014 FILED AS OF DATE: 20111017 DATE AS OF CHANGE: 20111017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baldassano Valli F. CENTRAL INDEX KEY: 0001416038 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19119 FILM NUMBER: 111143194 MAIL ADDRESS: STREET 1: 41 MOORES RD. CITY: FRAZER STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-10-14 1 0000873364 CEPHALON INC CEPH 0001416038 Baldassano Valli F. 41 MOORES RD. FRAZER PA 19355 0 1 0 0 Exec VP, Chief Compliance Off Common Stock 2011-10-14 4 D 0 73555 D 0 D Non-Qualified Stock Option 73.04 2011-10-14 4 D 0 50000 D 2011-11-07 2017-11-07 Common Stock 50000 0 D Incentive Stock Option 76.11 2011-10-14 4 D 0 5252 D 2011-12-13 2017-12-13 Common Stock 5252 0 D Non-Qualified Stock Option 76.11 2011-10-14 4 D 0 7248 D 2011-12-13 2017-12-13 Common Stock 7248 0 D Incentive Stock Option 73.25 2011-10-14 4 D 0 1365 D 2012-12-11 2018-12-11 Common Stock 1365 0 D Non-Qualified Stock Option 73.25 2011-10-14 4 D 0 48635 D 2012-12-11 2018-12-11 Common Stock 48635 0 D Incentive Stock Option 56.07 2011-10-14 4 D 0 1785 D 2013-12-02 2019-12-02 Common Stock 1785 0 D Non-Qualified Stock Option 56.07 2011-10-14 4 D 0 48215 D 2013-12-02 2019-12-02 Common Stock 48215 0 D Incentive Stock Option 63.11 2011-10-14 4 D 0 1584 D 2014-12-16 2020-12-16 Common Stock 1584 0 D Non-Qualified Stock Option 63.11 2011-10-14 4 D 0 48416 D 2014-12-16 2020-12-16 Common Stock 48416 0 D Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries, Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash. Includes 34,688 shares of Restricted Stock with certain vesting restrictions lapsed under the terms of the Merger Agreement at the Effective Time of the Merger. Options were cancelled at the Effective Time of the Merger pursuant to the terms of the Merger Agerement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option. Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant. Carolyn S. Iosca, Attorney-in-Fact for Valli F. Baldassano 2011-10-17